- Home
- TRS vs MNKD Comparison
TRS vs MNKD Comparison
Compare TRS & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRS
- MNKD
- Stock Information
- Founded
- TRS 1986
- MNKD 1991
- Country
- TRS United States
- MNKD United States
- Employees
- TRS N/A
- MNKD N/A
- Industry
- TRS Industrial Specialties
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- TRS Industrials
- MNKD Health Care
- Exchange
- TRS Nasdaq
- MNKD Nasdaq
- Market Cap
- TRS 1.5B
- MNKD 1.2B
- IPO Year
- TRS 2007
- MNKD 2004
- Fundamental
- Price
- TRS $40.02
- MNKD $5.61
- Analyst Decision
- TRS Strong Buy
- MNKD Strong Buy
- Analyst Count
- TRS 2
- MNKD 5
- Target Price
- TRS $45.00
- MNKD $10.80
- AVG Volume (30 Days)
- TRS 532.9K
- MNKD 5.9M
- Earning Date
- TRS 11-03-2025
- MNKD 11-06-2025
- Dividend Yield
- TRS 0.40%
- MNKD N/A
- EPS Growth
- TRS N/A
- MNKD 149.32
- EPS
- TRS 0.91
- MNKD 0.11
- Revenue
- TRS $973,840,000.00
- MNKD $301,736,000.00
- Revenue This Year
- TRS $11.03
- MNKD $16.36
- Revenue Next Year
- TRS $6.13
- MNKD $20.34
- P/E Ratio
- TRS $43.98
- MNKD $51.48
- Revenue Growth
- TRS 6.72
- MNKD 21.48
- 52 Week Low
- TRS $19.33
- MNKD $3.38
- 52 Week High
- TRS $40.00
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- TRS 67.72
- MNKD 67.37
- Support Level
- TRS $38.85
- MNKD $5.25
- Resistance Level
- TRS $39.69
- MNKD $5.77
- Average True Range (ATR)
- TRS 0.94
- MNKD 0.29
- MACD
- TRS -0.12
- MNKD -0.01
- Stochastic Oscillator
- TRS 99.58
- MNKD 65.29
About TRS TriMas Corporation
TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.